PHARMACORP RX INC (PCRX.CA) Forecast, Price Target & Analyst Ratings
TSX-V:PCRX • CA71714X1050
0.43 CAD
-0.01 (-1.15%)
Last: Mar 11, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PHARMACORP RX INC (PCRX.CA).
Forecast Snapshot
Consensus Price Target
CA$0.59
+ 36.40% Upside
Next Earnings Forecast
Release DateApr 20, 2026
PeriodQ4 / 2025
EPS EstimateCA$0.00
Revenue Estimate7.405M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$0.59
Upside
+ 36.40%
From current price of CA$0.43 to mean target of CA$0.59, Based on 6 analyst forecasts
Low
CA$0.51
Median
CA$0.59
High
CA$0.68
Price Target Revisions
1 Month
-11.54%
3 Months
N/A
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for PCRX.CA. The average price target is 0.59 CAD. This implies a price increase of 36.4% is expected in the next year compared to the current price of 0.43.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
PCRX.CA was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PCRX.CA.
In the previous month the buy percentage consensus was at a similar level.
PCRX.CA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 20, 2026
PeriodQ4 / 2025
EPS EstimateCA$0.00
Revenue Estimate7.405M
Revenue Q2Q68.33%
EPS Q2QN/A
Number of Analysts2
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
PCRX.CA is expected to report earnings on 4/20/2026. The consensus EPS estimate for the next earnings is 0 CAD and the consensus revenue estimate is 7.41M CAD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.795M | 20.742M 257.94% | 54.251M 161.55% | 77.77M 43.35% | |||
| EBITDA YoY % growth | N/A | N/A | -1.298M | 705.99K 154.37% | 6.379M 803.55% | 11.918M 86.83% | |
| EBIT YoY % growth | -563.2K -2,025.28% | -578K -2.63% | -1.588M -174.79% | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | -27.41% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | 0.00 | 0.02 | 0.03 100.00% |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 0.00 | 0.00 |
| Revenue Q2Q % growth | 7.405M 68.33% | 10.401M 159.57% |
| EBITDA Q2Q % growth | 383.8K -40.78% | 699.93K 68.37% |
| EBIT Q2Q % growth | N/A | N/A |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
64.40%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
137.64%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
111.82%
EBIT Next 5 Year
N/A
PHARMACORP RX INC / PCRX.CA Forecast FAQ
What is the average price target for PHARMACORP RX INC (PCRX.CA) stock?
6 analysts have analysed PCRX.CA and the average price target is 0.59 CAD. This implies a price increase of 36.4% is expected in the next year compared to the current price of 0.43.
What is the next earnings date for PCRX stock?
PHARMACORP RX INC (PCRX.CA) will report earnings on 2026-04-20.
What are the consensus estimates for PHARMACORP RX INC (PCRX.CA) next earnings?
The consensus EPS estimate for the next earnings of PHARMACORP RX INC (PCRX.CA) is 0 CAD and the consensus revenue estimate is 7.41M CAD.
How many analysts have analysed PHARMACORP RX INC (PCRX.CA)?
The number of analysts covering PHARMACORP RX INC (PCRX.CA) is 6.